Cafepharma Today

March 18 2019 - Amarin, AstraZeneca, and Abbott news from the American College of Cardiology meeting
Amarin, AstraZeneca, and Abbott news from the ACC meeting
Karuna looks past schizophrenia with series B funding
miR Scientific presents urine-based prostate cancer test
Merck KGaA signs another AI deal
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience. Read the latest answer -- about employment agreements under Chapter 11.

Today's most popular searches:

Current News

submit a press release
SPOTLIGHT on: CP's Therapeutic Specialties Messageboards
Bristol-Myers and Starboard Value spar over $74B Celgene buyout as shareholder vote looms
Endpoints
Tuesday, March 19, 2019 - 10:37am
tags:
Bristol-Myers Squibb, Starboard, Celgene, M&A
AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a treatment for multiple myeloma
Marketwatch
Tuesday, March 19, 2019 - 10:36am
tags:
AbbVie, venetoclax, Multiple Myeloma, FDA, clinical trials
Gilead raises prices on top-selling HIV treatments
Biopharma Dive
Tuesday, March 19, 2019 - 10:34am
tags:
Gilead Sciences, drug pricing, HIV
Apple Watch Atrial Fibrillation Study Has High Rate of False Positives
BioSpace
Tuesday, March 19, 2019 - 10:33am
tags:
Apple, Apple Watch, atrial fibrillation, false positives, American College of Cardiology, wearables, devices
Zoll reveals data breach during email server migration
Mass Device
Tuesday, March 19, 2019 - 10:31am
tags:
ZOLL Medical, cybersecurity, devices, patients
Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Endpoints
Tuesday, March 19, 2019 - 10:30am
tags:
Axovant, Alzheimer's disease, Roivant, Vivek Ramaswamy, Urovant, vibegron, urinary incontinence
Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA
BioSpace
Tuesday, March 19, 2019 - 10:29am
tags:
Allergan, migraines, ubrogepant, FDA
Women’s History Month: 10 Women Biopharma Pioneers
BioSpace
Monday, March 18, 2019 - 11:50pm
tags:
biotech, women
Partnering talks led to Biogen’s $800M Nightstar buyout as players clustered around the hot deal table for gene therapies
Endpoints
Monday, March 18, 2019 - 11:48pm
tags:
Biogen, gene therapy, Nightstar Therapeutics, M&A
Behind the Numbers: FDA Offers Budget Specifics, New Proposals
RAPS.org
Monday, March 18, 2019 - 11:46pm
tags:
FDA, opioid crisis, generics, devices
Novartis’ Alcon picks up PowerVision for $285m
Mass Device
Monday, March 18, 2019 - 5:09pm
tags:
Novartis, Alcon, PowerVision, M&A, interocular lens, devices
New shareholder challenge to Gilead: What are you doing with billions in tax savings?
Bizjournals
Monday, March 18, 2019 - 5:06pm
tags:
Gilead Sciences, taxes, tax reform
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Fierce Pharma
Monday, March 18, 2019 - 5:05pm
tags:
Novo Nordisk, diabetes, Teva Pharmaceutical, Victoza, semaglutide
Exclusive: Sanofi says working on CEO succession plan
Yahoo/Reuters
Monday, March 18, 2019 - 5:04pm
tags:
Sanofi, Pharma CEOs, Olivier Brandicourt
Dermira shares double on positive eczema data
Biopharma Dive
Monday, March 18, 2019 - 5:03pm
tags:
Dermira, lebrikizumab, clinical trials, eczema
ACC 2019: Abbott touts reduced stroke, bleeding and pump-clotting in HeartMate 3 trial
Mass Device
Monday, March 18, 2019 - 12:19pm
tags:
Abbott Labs, devices, HeartMate 3, American College of Cardiology, strokes
An AIDS therapy involving parasite injections was discredited. China is reviving it — for cancer
Stat
Monday, March 18, 2019 - 12:18pm
tags:
Henry Heimlich, China, malarial therapy, cancer
ACC: AstraZeneca's Farxiga chops follow-up CV events by 16% in heart attack patients with diabetes
Fierce Pharma
Monday, March 18, 2019 - 12:16pm
tags:
AstraZeneca, Farxiga, American College of Cardiology
Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
Stat
Monday, March 18, 2019 - 12:14pm
tags:
Amarin, Vascepa, American College of Cardiology
Biohaven is betting hundreds of millions it can hustle ahead of rivals in a blockbuster race. A quick M&A deal could pay off backers big time
Endpoints
Monday, March 18, 2019 - 12:13pm
tags:
Biohaven, migraines, rimegepant

Pages

Latest CP Wire Articles

miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
Life Science Research Provider Files for $100 Million IPO
American College of Cardiology Conference Roundup - day 1
Microbiome Report for Week Ending 3/9/19
Proteon Therapeutics Files for $50 Million Offering
Healthcare Focused Fund to Invest $100 Million in Harvard Drug Development
Microbiome Report for Week Ending 3/2/19
Novo Nordisk Launches Innovation Platform in China
Synlogic Achieves Milestone in Development of Synthetic Biotic for IBD
Infant Bacterial Therapeutics AB Announces Distribution Agreement For Israeli Market

Latest Pharmagather Articles

How Blockchain Can Support FDA s Agenda
pharmexec r&d
Administration Acts Fast to Smooth Transition to New FDA Commissioner
pharmexec r&d
How Blockchain Can Support FDA s Agenda
pharmexec technology
John Crowley: Living the Mission
pharmexec top feature
Drug Industry Consolidation Refuses To Arrive So Quickly
In the Pipeline
CBI’s Real-Time Benefit Check & ePrior Authorization Summit
Drug Channels
Why Patient Engagement Is Important For Your Pharmacy
Digital Pharma Blog
Patients is a Virtue
pharmexec top feature
Zafgen: Will There Be a Third Act?
In the Pipeline
Pharma Jobs from Indeed


Pharma and Device News from NASDAQ

Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results
Tuesday, March 19, 2019 - 7:30am
CORRECTION – AquaBounty Technologies, Inc.
Tuesday, March 19, 2019 - 7:14am
Incysus Therapeutics to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting 2019
Tuesday, March 19, 2019 - 7:00am
AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock
Tuesday, March 19, 2019 - 6:00am
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
Monday, March 18, 2019 - 4:20pm
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
Monday, March 18, 2019 - 4:05pm
AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock
Monday, March 18, 2019 - 4:00pm
Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at ACC.19
Monday, March 18, 2019 - 4:00pm
Adverum Biotechnologies to Participate in Upcoming Conferences
Monday, March 18, 2019 - 9:00am
Jim Crone, President and Interim CFO of True Nature Holding, Inc., is Featured in a New Audio Interview with SmallCapVoice.com
Monday, March 18, 2019 - 8:30am

Breaking Healthcare News - powered by Seeking Alpha

CASI Pharma on go to start pivotal study of Marqibo in China
Thursday, March 7, 2019 - 9:42am
22nd Century reports Q4 results
Thursday, March 7, 2019 - 9:35am
Cantor likes Unity Biotech, shares up 15% premarket
Thursday, March 7, 2019 - 9:26am
Zealand Pharma reports FY results
Thursday, March 7, 2019 - 9:18am
Roche files U.S. application for expanded use of Venclexta
Thursday, March 7, 2019 - 8:57am
Merck KGaA reports Q4 results
Thursday, March 7, 2019 - 8:55am
FDA accepts Foamix NDA for acne treatment FMX101; shares up 4% premarket
Thursday, March 7, 2019 - 8:41am
Orchard gene therapy shows positive action in rare inherited immune deficiency disorder
Friday, February 22, 2019 - 9:26am
Diplomat -19% on delaying 10-K filing
Friday, February 22, 2019 - 8:54am
Alder Bio files U.S. marketing application for migraine med eptinezumab
Friday, February 22, 2019 - 8:51am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.